Categories AlphaGraphs, Earnings, Health Care

Abbott Laboratories ease past street targets: Infographic

Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q2 sales of $ 10.2 billion, up 40% year-over-year and higher than the Wall Street projection. Net income of $1.17 per share was also above the target that analysts had anticipated.

ABT shares rose 0.4% immediately following the announcement. The stock has gained 9% since the beginning of this year.

Abbott Laboratories Q2 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Abbott Laboratories Q2 earnings call transcript

Prior performance

  • ABBOTT REPORTS THIRD-QUARTER 2020 RESULTS; ACHIEVES STRONG DOUBLE-DIGIT EARNINGS GROWTH AND RAISES GUIDANCE
  • Abbott Laboratories Q2 2020 earnings infographic

Most Popular

WBA Earnings Preview: Will Walgreens’ Q3 report bring cheer to investors?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been facing challenges due to higher operating costs, rising competition, and an unfavorable retail environment. These factors have put pressure on the drugstore

Main points from Accenture’s (ACN) Q3 2024 earnings report

Shares of Accenture (NYSE: ACN) rose 6% on Thursday, following the company’s announcement of its third-quarter 2024 earnings results. Although revenue and profits missed expectations, the stock jumped after the

ACB Earnings: Aurora Cannabis reports narrower Q4 loss on higher revenues

Aurora Cannabis, Inc. (NASDAQ: ACB) on Thursday reported a net loss for the fourth quarter of 2024. The company’s revenues moved up 5% year-over-year during the quarter. The Canada-based recreational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top